Acute, Severe Cryptosporidiosis in an Immunocompetent Pediatric Patient

Caitlin Tallant1, Patrick Huddleston1, Asim Alshanberi2

  • 1School of Medicine, Texas Tech University Health Sciences Center , Amarillo, TX, USA.

Clinics and Practice
|August 2, 2016
PubMed

Insights

Severe diarrhea in children can be caused by cryptosporidium. Early stool testing for this parasite, especially with livestock contact, aids prompt diagnosis and treatment.

Area of Science:

  • Microbiology
  • Pediatrics
  • Infectious Diseases

Background:

  • Severe diarrheal illness in children often requires microbiological testing for accurate diagnosis.
  • Delayed diagnosis can impede timely and effective treatment.
  • Cryptosporidium is a known cause of pediatric diarrhea, with potential zoonotic transmission from cattle.

Observation:

  • A case of acute cryptosporidiosis in an immunocompetent pediatric patient is presented.
  • The patient experienced multiple days of severe diarrhea.

Findings:

  • Cryptosporidium infection was diagnosed in the pediatric patient.
  • The study highlights the potential for zoonotic transmission from bovine species.

Implications:

  • Consider diagnostic tests for cryptosporidium, such as Ziehl-Neelsen staining or rapid antigen detection, in children with severe undifferentiated diarrhea.
  • This is particularly important for children with close contact with livestock.
  • Early identification can prevent diagnostic delays and improve patient outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
679
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419